Latest Breaking News On - Optimus oncology initiative - Page 1 : comparemela.com

InvestorNewsBreaks – Processa Pharmaceuticals Inc (NASDAQ: PCSA) Closes on $7M Public Offering

InvestorNewsBreaks – Processa Pharmaceuticals Inc (NASDAQ: PCSA) Closes on $7M Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Los angelesProcessa pharmaceuticalsOptimus oncology initiativeProcessa pharmaceuticals incHc wainwright coRegulatory science approachOptimal dosage regimenNext generation capecitabineNext generation gemcitabineNext generation irinotecanDynamic brand portfolio

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bret shapiroPatrick linProcessa ngcsCompany contactPharmaceuticals incDear processa pharmaceuticals shareholdersStraits researchOptimus oncology initiativeProcessa pharmaceuticals incCompany next generation chemotherapyProcessa pharmaceuticalsProcessa teamStable financial affairsBusiness development opportunitiesProcessa pharmaceuticals shareholdersRegulatory science approach

Processa Pharmaceuticals Issues Letter to Shareholders

HANOVER, MD, Nov. 29, 2023 (GLOBE NEWSWIRE) Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage.

Processa ngcsBret shapiroPatrick linDear processa pharmaceuticals shareholdersStraits researchProcessa pharmaceuticalsOptimus oncology initiativeCompany contactStable financial affairsProcessa pharmaceuticals incCompany next generation chemotherapyProcessa teamPharmaceuticals incBusiness development opportunitiesProcessa pharmaceuticals shareholdersRegulatory science approach

Processa Pharmaceuticals, Inc (NASDAQ:PCSA) Q3 2022 Earnings Call Transcript

Operator: Greetings, and welcome to Processa Pharmaceuticals third-quarter 2022 earnings call and corporate update. At this time, all participants are in a listen-only mode.

South koreaFrancois briseboisMike floydJim stankerDavid youngProcessa pharmaceuticals incLife insurance companiesOptimus initiativeOptimus oncology initiativeProcessa pharmaceuticalsCall transcript novemberChief financialRaimond klavinsChief executive officerChief operating officerInvestor relations

Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update

Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Patrick linDavid youngMichael floydProcessa pharmaceuticals incOptimus oncology initiativePharmaceuticals incProcessa pharmaceuticalsWall streetGeneration capecitabineNext generation capecitabineProject optimus oncology initiativeNew drug applicationsNine monthsCall replay informationtoll freeMore information